Pathogenesis of steatohepatitis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 663-678

  Day, C P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cytokines; Fatty acids; Insulin resistance; Lipid peroxidation; Mitochondria; Obesity; Reactive oxygen species; Steatohepatitis; Steatosis; Type 2 diabetes; Uncoupling proteins

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ACYL COENZYME A; APOLIPOPROTEIN E; CYTOCHROME P450; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; CYTOKINE; FATTY ACID; GAMMA INTERFERON; HFE PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 8; IRON; MANGANESE SUPEROXIDE DISMUTASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2;

ALCOHOL CONSUMPTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; FATTY LIVER; HEPATITIS; HEREDITY; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER MICROSOME; LIVER MITOCHONDRION; OBESITY; PATHOGENESIS; REVIEW; ELECTRON TRANSPORT; FATTY ACID OXIDATION; GENETIC ASSOCIATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

CYTOKINES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; OBESITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036780582     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0333     Document Type: Article

References (87)

1. Byron D Minuk G Y Profile of an urban hospital-based practice Hepatology 24 1996 813-815
2. Skelly M M James P D Ryder S D Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology Journal of Hepatology 35 2001 195-199
3. James O FW Day C P Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance Journal of Hepatology 29 1998 495-501
4. Matteoni C A Younossi Z M Gramlich T et al. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413-1419
5. Caldwell S H Oelsner D H Lezzoni J C et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664-670
6. Poonwala A Nair S Thuluvath P J Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689-692
7. Day C P James OFW Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842-845
8. Sanyal A J Campbell-Sargent C Mirshahi F et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183-1192
9. Marchesini G Brizi M Bianchi G et al. Non-alcoholic fatty liver disease. A feature of the metabolic syndrome Diabetes 50 2001 1844-1850
10. Day C P James O FW Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463-1465
11. Wanless I R Lentz J S Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106-1110
12. Garcia-Monzon C Martin-Perez E Lo Iacono O et al. Characterization of pathogenic and prognostic factors of non-alcoholic statohepatitis associated with obesity Journal of Hepatology 33 2000 716-724
13. Sorenson T I A Orholm M Bentsen K D et al. Prospective evaluation of alcohol abuse and alcohol liver injury in men as predictors of development of cirrhosis Lancet ii 1984 241-244
14. Teli M R Day C P Burt A D et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 246 1995 987-990
15. Adinolfi L E Gambardella M Andreana A et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358-1364
16. Reeves H L Burt A D Wood S Day C P Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis Journal of Hepatology 25 1996 677-683
17. Cortez-Pinto H Baptista A Camilo M E Moura M C Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis Hepato-Gastroenterology 48 2001 87-90
18. Stewart S F Jones D EJ Day C P Alcoholic liver disease: new insights into mechanisms and preventative strategies Trends in Molecular Medicine 7 2001 408-413
19. Leclerq I A Farrell G C Field J et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis Journal of Clinical Investigation 105 2000 1067-1075
20. Letteron P Fromenty B Terris B et al. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice Journal of Hepatology 24 1996 200-208
21. Pessayre D Berson A Fromenty B Mansouri A Mitochondria in steatohepatitis Seminars in Liver Disease 21 2001 57-69
22. Cortez-Pinto H Oxidative stress in alcoholic and non-alcoholic liver disease In Leuschner U James OFW Dancygier H (eds) Steatohepatitis (NASH and ASH) 2001 54-61 Kluwer Academic Publishers Dordrecht
23. Lancaster J R Laster S M Gooding L R Inhibition of target cell mitochondrial electron transfer by tumour necrosis factor FEBS Letters 248 1989 169-174
24. Yang S Q Zhu H Li Y et al. Mitochondrial adaptations to obesity-related oxidant stress Archives of Biochemistry and Biophysics 378 2000 259-268
25. 2 generation in liver mitochondria Carcinogenesis 21 2000 983-989
26. Hruszkewycz A M Evidence for mitochondrial DNA damage by lipid peroxidation Biochemical and Biophysical Research Communications 153 1988 191-197
27. Garcia-Ruiz C Collel A Morales A et al. Role of oxidative stress generated from mitochondrial electron transport chain and mitochondrial electron status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes Molecular Pharmacology 48 1995 8250-8345
28. Weltman M D Farrell G C Hall P et al. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis Hepatology 27 1998 128-133
29. George D K Goldwurm S Macdonald G A et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311-318
30. Younossi Z M Gramlich T Bacon B R et al. Hepatic iron and non-alcoholic fatty liver disease Hepatology 30 1999 847-850
31. Caldwell S H Swerdlow R H Khan E M et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis Journal of Hepatology 31 1999 430-434
32. Cortez-Pinto H Chatham J Chacko V P et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis. A pilot study Journal of the American Medical Association 282 1999 1659-1664
33. Cortez-Pinto H Lin H Z Yang S Q Da Costa S OD Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes Gastroenterology 116 1999 1184-1193
34. Drenick E J Fisler J Johnson D Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole irrespective of protein-calorie malnutrition Gastroenterology 83 1982 534-548
35. Yang S Q Lin H Z Lane M D et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proceedings of the National Academy of Science of the USA 94 1997 2557-2562
36. Guebre-Xabier M Yang S Lin H Z et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitisation to liver damage Hepatology 31 2000 633-640
37. Crespo J Cayon A Fernandez-Gil P et al. Gene expression of tumour necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158-1163
38. Kern P A Saghizadeh M Ong J M et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase Journal of Clinical Investigation 95 1995 2111-2119
39. Wigg A J Roberts-Thomson I C Dymock R B et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis Gut 48 2001 206-211
40. Dixon J B Bhathal P S O'Brien P E Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91-100
41. Poullis A Mendall M A Alcohol, obesity, and TNFα Gut 49 2001 313
42. Chavin K D Yang S Q Lin H Z et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion Journal of Biological Chemistry 274 1999 5692-5700
43. Echtay K S Roussel D St-Pierre J et al. Superoxide activates mitochondrial uncoupling proteins Nature 415 2002 96-99
44. Hui A M Kawasaki S Makuuchi M et al. Liver injury following normothermic ischemia in steatotic rat liver Hepatology 20 1994 1287-1293
45. Yang S Q Lin H Z Mandal A K et al. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology Hepatology 34 2001 694-706
46. Zhou Y T Grayburn P Karim A et al. Lipotoxic heart disease in obese rats: implications for human obesity Proceedings of the National Academy of Science of the USA 97 2000 1784-1789
47. Ruderman N B Saha A K Vavvas D Witters L A Malonyl-CoA, fuel sensing, and insulin resistance American Journal of Physiology 276 1999 E1-E18
48. Unger R H Zhou Y-T Orci L Regulation of fatty acid homeostasis in cells: novel role of leptin Proceedings of the National Academy of Science of the USA 96 1999 2327-2332
49. Pagano G Pacinin G Musso G et al. Nonalcoholic steatohepatitis, insulin resistance, metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367-372
50. Chitturi S Abeygunasekera S Farrell G C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373-379
51. Angulo P Keach J C Batts K P et al. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis Hepatology 30 1999 1356-1362
52. Ratziu V Giral P Charlotte F et al. Liver fibrosis in overweight patients Gastroenterology 118 2000 1117-2113
53. Day C P Yeaman S J The biochemistry of alcoholic fatty liver Biochimica et Biophysica Acta 1215 1994 33-48
54. Bjorntorp P Bergman H Varnauskas E Plasma free fatty acid turnover in obesity Acta Medica Scandinavica 185 1969 351-356
55. Jensen M D Haymond M W Rizza R A et al. Influence of body fat distribution on free fatty acid metabolism in obesity Journal of Clinical Investigation 83 1989 1168-1173
56. Arner P Not all fat is alike Lancet 351 1998 1301-1302
57. McTernan C L McTernan P G Harte A L et al. Resistin, central obesity, and type 2 diabetes Lancet 359 2002 46-47
58. Bujalska I J Kumar S Stewart P M Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349 1997 1210-1213
59. Andrews R C Walker B R Glucocorticoids and insulin resistance: old hormones, new targets Clinical Science 966 1999 513-523
60. Uysal K T Wiesbrock S M Marino M W Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610-614
61. Yuan M Konstantopoulos N Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ Science 293 2001 1673-1677
62. Birnbaum M J Turning down insulin signaling Journal of Clinical Investigation 108 2001 655-659
63. Kim J K Kim Y-J Fillmore J J et al. Prevention of fat-induced insulin resistance by salicylate Journal of Clinical Investigation 108 2001 437-446
64. Clarke S D Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription American Journal of Physiology: Gastrointestinal and Liver Physiology 281 2001 G865-G869
65. Kahn B B Flier J Obesity and insulin resistance Journal of Clinical Investigation 106 2000 473-481
66. Shulman G I Cellular mechanisms of insulin resistance Journal of Clinical Investigation 106 2000 171-176
67. Powell E E Searle J Mortimer R Steatohepatitis associated with limb lipodystrophy Gastroenterology 97 1989 1022-1024
68. Martinelli A C Viana C F Montenegro R M et al. Nonalcoholic fatty liver disease and familial partial lipodystrophy - a strong association Hepatology 34 2001 461 (abstract)
69. Lee Y Wang M Y Kakuma T et al. Liporegulation in diet-induced obesity: the antisteatotic role of hyperleptinemia Journal of Biological Chemistry 276 2001 5629-5635
70. Minokoshi Y Kim Y-B Peroni O D et al. Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339-343
71. Zhou G Myers R Li Y et al. Role of AMP-activated protein kinase in the mechanism of metformin action Journal of Clinical Investigation 108 2001 1167-1174
72. Letteron P Brahimi-Bourouni N Robin M A et al. Glucocorticoids inhibit mitochondrial matrix acyl-coenzyme A dehydrogenases and fatty acid β-oxidation American Journal of Physiology 272 1997 G1141-G1150
73. Woodcroft K J Hafner M S Novak R Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression Hepatology 35 2002 263-273
74. Reddy J K Nonalcoholic steatosis and steatohepatitis III. Peroxisomal β-peroxidation, PPARα, and steatohepatitis American Journal of Physiology 281 2001 G1333-G1339
75. Fan C-Y Usuda N Yeldandi A V et al. Steatohepatitis, spontaneous peroxisome proliferation and liver tumours in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism Journal of Biological Chemistry 273 1998 15639-15645
76. Paradis V Perlemuter G Bonvoust F et al. High glucose and hyperinsulinaemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738-744
77. Honda, H, Ikejima, K, Hirose, M, et al. Leptin is required for fibrogenic responses in the murine liver induced by thioacetamide, Hepatology (in press)
78. Saxena N K Ikeda K Rockey D C Friedman S L Anania F A Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice Hepatology 35 2002 762-771
79. Zein N N Abdulkarim A S Wiesner R H et al. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol and cholestatic disease Journal of Hepatology 32 2000 209-217
80. Erbey J R Silberman C Lydick E Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes American Journal of Medicine 109 2000 588-589
81. Struben V M D Hespenheide E E Caldwell S H Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds American Journal of Medicine 108 2000 9-13
82. Willner I R Waters B Patil S R et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease American Journal of Gastroenterology 96 2001 2957-2961
83. Day C P Daly A K The genetic basis for non-alcoholic and alcoholic steatohepatitis In Leuschner U James OFW Dancygier H (eds.) Steatohepatitis (NASH and ASH) 2001 43-53 Kluwer Academic Publishers Dordrecht
84. Marchesini G Brizi M Bianchi G et al. Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893-894
85. Masuzaki H Paterson J Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome Science 294 2001 2166-2170
86. Bernard S Touzet S Personne I et al. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes Diabetologia 43 2000 995-999
87. Shimoda-Matsubayashi S Matsumine H Kobayashi T et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene Biochemical and Biophysical Research Communications 226 1996 561-565